Mycophenolic acid and cancer risk in solid organ transplant recipients: Systematic review and meta‐analysis-Reference-Cited by-同舟云学术

Mycophenolic acid and cancer risk in solid organ transplant recipients: Systematic review and meta‐analysis

Published:2021-07-29 Issue:2 Volume:88 Page:476-489
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Brit J Clinical Pharma

Author:

Hirunsatitpron Pannaphak¹²,Hanprasertpong Nutthiya¹,Noppakun Kajohnsak³⁴,Pruksakorn Dumnoensun⁵⁶⁷,Teekachunhatean Supanimit¹,Koonrungsesomboon Nut¹⁵^ORCID

Affiliation:

1. Department of Pharmacology, Faculty of Medicine Chiang Mai University Thailand

2. Master's Degree Program in Pharmacology, Faculty of Medicine Chiang Mai University Thailand

3. Division of Nephrology, Department of Internal Medicine, Faculty of Medicine Chiang Mai University Thailand

4. Pharmacoepidemiology and Statistics Research Center, Faculty of Pharmacy Chiang Mai University Thailand

5. Musculoskeletal Science and Translational Research Center, Faculty of Medicine Chiang Mai University Thailand

6. Omics Center for Health Science, Faculty of Medicine Chiang Mai University Thailand

7. Biomedical Engineering Institute Chiang Mai University Thailand

Funder

National Science and Technology Development Agency

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14979

Reference98 articles.

1. Mycophenolate Mofetil

2. Current strategies and future trends in immunosuppression after heart transplantation

3. Immunosuppression in liver transplant

4. Mycophenolate mofetil and its mechanisms of action

5. Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuropsychiatric Systemic Lupus Erythematosus: Molecules Involved in Its Imunopathogenesis, Clinical Features, and Treatment;Molecules;2024-02-06

2. Safety of Immunomodulatory Systemic Therapies Used in the Management of Immune-Related Cutaneous Adverse Events;Pharmaceuticals;2023-11-15

3. Expert consensus on the systemic treatment of atopic dermatitis in special populations;Journal of the European Academy of Dermatology and Venereology;2023-02-08

4. Management of Cancer-Associated Myositis;Current Treatment Options in Rheumatology;2022-10-21

5. Novel amides of mycophenolic acid and some heterocyclic derivatives as immunosuppressive agents;Journal of Enzyme Inhibition and Medicinal Chemistry;2022-10-03